The discovery of a new and more contagious COVID-19 variant derailed South Africa’s plans to begin immunising its health workers with the Oxford-AstraZeneca vaccine, which proved less effective against the new strain.
By mid-December, the country entered its second wave of the pandemic, at its peak recording 20,000 new infections a day.
For now, South Africa is using the Johnson & Johnson vaccine, which was shown to be more effective and will instead distribute its batch of Oxford-AstraZeneca vaccines to other African countries.
Al Jazeera’s Fahmida Miller reports from a lab in KwaZulu-Natal, South Africa.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#SouthAfrica #COVID-19 #Coronavirus
By mid-December, the country entered its second wave of the pandemic, at its peak recording 20,000 new infections a day.
For now, South Africa is using the Johnson & Johnson vaccine, which was shown to be more effective and will instead distribute its batch of Oxford-AstraZeneca vaccines to other African countries.
Al Jazeera’s Fahmida Miller reports from a lab in KwaZulu-Natal, South Africa.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#SouthAfrica #COVID-19 #Coronavirus
- Category
- World
- Tags
- africa, covid, al jazeera
Sign in or sign up to post comments.
Be the first to comment